Displaying 201–221 of 221 results for Paul Thomas, Managing Editor
Director Michael Moore is pointing his lens toward the pharmaceutical industry, and drug company employees are on high alert. Love Moore or hate him, enjoy the limelight while it lasts, says Managing Editor Paul Thomas. Besides, an encounter might also be an opportunity to talk about the positive...
The drug importation issue: Stopping prescription drug shipments to online Canadian pharmacies only diverts attention from key safety and affordability issues, and a clear solution: track and trace technologies.
Remember isotopes from Chemistry 101? As used in Stable Isotope Analysis, they offer a surefire way to authenticate APIs and products without additives. John P. Jasper, who helped pioneer the technology, discusses what it can do and where it's heading.
Of the top 10 best-selling drugs in 2003, just one was a first-in-class product J&Js Procrit. The other nine were latecomers, designed specifically to be best-in-class, that were able to overtake the early market entrant.
The growth of generic drug manufacturing operations has challenged the pharmaceutical industry, legally, technologically and ethically. Generics manufacturers have injected some healthy competition into the industry, but they also have drug inventors scrambling to protect their hard-won ...
FDA wants its drug investigators to go to a higher level. Can they get there? Will they really make a difference?
The humanitarian aid following Decembers tsunami in south and southeast Asia has been unprecedented, and inspirational. Big players in the pharmaceutical industry have stepped up, with cash and supplies. Here are some initial, unofficial commitments.
Stewardship concerns led Baxter Healthcare to create EthicsKit, an online guide to building an ethics program from scratch. Integrity led the company to share it.
pharmaceutical manufacturing multimedia presentations